IBUPROFEN TABLETS, COATED

IBUPROFEN TABLETS, COATED was reported 42678 times

IBUPROFEN TABLETS, COATED is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT 33 0.1320
1 GRIP STRENGTH 27 0.1179
2 PRODUCT COATING ISSUE 83 0.0813
3 PRODUCT DIFFICULT TO SWALLOW 61 0.0600
4 POOR QUALITY DRUG ADMINISTERED 358 0.0553
5 C-REACTIVE PROTEIN 40 0.0431
6 FOREIGN BODY 172 0.0429
7 FOREIGN BODY IN RESPIRATORY TRACT 54 0.0412
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 81 0.0404
9 REACTION TO DRUG EXCIPIENTS 75 0.0345
10 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 939 0.0320
11 DRUG EFFECT DELAYED 143 0.0315
12 RETINITIS 53 0.0307
13 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 62 0.0299
14 PRODUCT SHAPE ISSUE 27 0.0286
15 PRODUCT COMMINGLING 30 0.0282
16 FACET JOINT SYNDROME 91 0.0279
17 BLOOD PRESSURE DIASTOLIC ABNORMAL 70 0.0275
18 BLOOD PRESSURE SYSTOLIC ABNORMAL 68 0.0275
19 DISLOCATION OF VERTEBRA 60 0.0263
20 LUPUS VULGARIS 33 0.0262
21 X-RAY ABNORMAL 45 0.0251
22 SWOLLEN JOINT COUNT INCREASED 67 0.0210
23 PORPHYRIA ACUTE 29 0.0202
24 SKIN PAPILLOMA 79 0.0197
25 PRODUCT USED FOR UNKNOWN INDICATION 24 0.0191
26 RHEUMATIC FEVER 85 0.0190
27 PERIPHERAL VENOUS DISEASE 77 0.0188
28 BILIARY DYSKINESIA 31 0.0183
29 FOREIGN BODY IN THROAT 56 0.0178
30 PRODUCT TASTE ABNORMAL 236 0.0174
31 BONE EROSION 59 0.0167
32 C-REACTIVE PROTEIN ABNORMAL 100 0.0156
33 PRE-EXISTING CONDITION IMPROVED 97 0.0155
34 PRODUCT SIZE ISSUE 83 0.0154
35 DUODENAL ULCER PERFORATION 110 0.0148
36 THERAPEUTIC PRODUCT EFFECT VARIABLE 57 0.0147
37 DRUG EFFECT INCOMPLETE 527 0.0145
38 ORAL DISCOMFORT 199 0.0143
39 RHEUMATOID FACTOR POSITIVE 82 0.0142
40 PRODUCT COLOUR ISSUE 70 0.0136
41 AUTOIMMUNE DISORDER 132 0.0135
42 PRODUCT PHYSICAL ISSUE 270 0.0134
43 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 86 0.0132
44 CHOLECYSTITIS CHRONIC 88 0.0131
45 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 93 0.0130
46 MUSCLE INJURY 107 0.0129
47 LIP DRY 115 0.0126
48 EPIGASTRIC DISCOMFORT 49 0.0125
49 THROMBOPHLEBITIS SUPERFICIAL 38 0.0125
50 BLOOD PRESSURE DIASTOLIC INCREASED 55 0.0119
51 GRIP STRENGTH DECREASED 103 0.0117
52 THERAPEUTIC PRODUCT EFFECT DELAYED 53 0.0116
53 BREAST CANCER STAGE III 75 0.0116
54 OESOPHAGEAL PAIN 45 0.0114
55 COELIAC DISEASE 111 0.0113
56 EXOSTOSIS 103 0.0113
57 VITAMIN B12 DECREASED 32 0.0111
58 GASTRIC ULCER HAEMORRHAGE 60 0.0108
59 JOINT RANGE OF MOTION DECREASED 145 0.0108
60 MENOPAUSAL SYMPTOMS 25 0.0107
61 BURSITIS 128 0.0105
62 CARTILAGE INJURY 26 0.0105
63 SEDATION 275 0.0105
64 PRODUCT LABEL ISSUE 70 0.0103
65 SCIATICA 163 0.0102
66 ULCER HAEMORRHAGE 69 0.0102
67 DRUG EFFECT LESS THAN EXPECTED 148 0.0100
68 TONGUE DISCOMFORT 42 0.0099
69 GLOSSODYNIA 221 0.0099
70 SYNOVIAL CYST 45 0.0097
71 HYPOAESTHESIA ORAL 146 0.0097
72 THROAT IRRITATION 432 0.0096
73 HELICOBACTER INFECTION 97 0.0094
74 GASTRIC HAEMORRHAGE 108 0.0094
75 IRRITABLE BOWEL SYNDROME 201 0.0094
76 FOLLICULITIS 97 0.0092
77 GASTRIC ULCER 175 0.0092
78 NIGHTMARE 317 0.0092
79 GASTRIC DISORDER 311 0.0091
80 PRODUCT USE COMPLAINT 141 0.0089
81 POOR QUALITY PRODUCT ADMINISTERED 94 0.0089
82 DRUG TOLERANCE DECREASED 25 0.0089
83 EXPIRED DRUG ADMINISTERED 44 0.0089
84 HANGOVER 31 0.0088
85 BLOOD PRESSURE DIASTOLIC DECREASED 65 0.0088
86 HYPERCHOLESTEROLAEMIA 84 0.0087
87 INTERVERTEBRAL DISC DEGENERATION 80 0.0086
88 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 58 0.0085
89 CONGENITAL ANOMALY 66 0.0085
90 PRODUCT ODOUR ABNORMAL 89 0.0085
91 PARANASAL SINUS DISCOMFORT 32 0.0084
92 TENDON DISORDER 54 0.0083
93 PRODUCT FORMULATION ISSUE 54 0.0082
94 THERAPEUTIC RESPONSE UNEXPECTED 360 0.0080
95 ANKYLOSING SPONDYLITIS 105 0.0080
96 FOOT DEFORMITY 88 0.0079
97 SYNOVITIS 142 0.0079
98 ABDOMINAL DISCOMFORT 1307 0.0078
99 WOUND INFECTION 85 0.0078
100 ROSACEA 36 0.0077
101 DYSPEPSIA 755 0.0077
102 EAR DISORDER 35 0.0076
103 INFUSION SITE PRURITUS 24 0.0076
104 BODY TEMPERATURE DECREASED 74 0.0075
105 CHOKING 146 0.0075
106 MATERNAL EXPOSURE TIMING UNSPECIFIED 28 0.0074
107 HAND DEFORMITY 97 0.0074
108 NEPHROLITHIASIS 339 0.0074
109 WEIGHT FLUCTUATION 77 0.0074
110 BODY HEIGHT DECREASED 78 0.0073
111 PRODUCT USE IN UNAPPROVED INDICATION 1802 0.0073
112 CYTOLYTIC HEPATITIS 24 0.0072
113 TENSION HEADACHE 31 0.0072
114 CORONARY ARTERY STENOSIS 36 0.0072
115 PLANTAR FASCIITIS 24 0.0071
116 SNORING 27 0.0071
117 WALKING AID USER 47 0.0071
118 INTENTIONAL PRODUCT MISUSE 623 0.0071
119 NERVE COMPRESSION 65 0.0070
120 EAR INFECTION 187 0.0070
121 SPONDYLITIS 25 0.0069
122 ULCER 108 0.0068
123 DECREASED INTEREST 40 0.0068
124 DIVERTICULUM 48 0.0067
125 OESOPHAGEAL DISORDER 26 0.0067
126 LOWER LIMB FRACTURE 129 0.0067
127 MUSCLE STRAIN 58 0.0067
128 SEASONAL ALLERGY 93 0.0066
129 PEMPHIGUS 82 0.0066
130 MULTIPLE ALLERGIES 51 0.0065
131 FEELING OF BODY TEMPERATURE CHANGE 38 0.0065
132 NIGHT SWEATS 207 0.0064
133 BONE LESION 23 0.0064
134 SUSPECTED COUNTERFEIT PRODUCT 25 0.0063
135 MUSCULOSKELETAL PAIN 331 0.0063
136 EXPIRED PRODUCT ADMINISTERED 208 0.0063
137 LIP SWELLING 206 0.0062
138 SINUSITIS 625 0.0061
139 EAR PAIN 118 0.0061
140 SENSATION OF FOREIGN BODY 51 0.0060
141 NEPHROGENIC ANAEMIA 28 0.0060
142 SPINAL OSTEOARTHRITIS 53 0.0060
143 DYSGEUSIA 446 0.0060
144 EYE SWELLING 223 0.0060
145 MUSCULOSKELETAL STIFFNESS 525 0.0060
146 POST-TRAUMATIC STRESS DISORDER 40 0.0060
147 FIBROMYALGIA 145 0.0060
148 OBESITY 95 0.0060
149 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 327 0.0060
150 DRUG TOLERANCE 30 0.0059
151 RED BLOOD CELL SEDIMENTATION RATE INCREASED 65 0.0059
152 JOINT DISLOCATION 62 0.0059
153 INFLAMMATORY MARKER INCREASED 29 0.0058
154 INCREASED UPPER AIRWAY SECRETION 30 0.0058
155 MIGRAINE 549 0.0057
156 CONTRAINDICATED PRODUCT ADMINISTERED 174 0.0057
157 LUPUS-LIKE SYNDROME 52 0.0057
158 MIDDLE INSOMNIA 107 0.0057
159 BLOOD CHOLESTEROL INCREASED 267 0.0057
160 ABDOMINAL PAIN UPPER 1178 0.0057
161 INFLAMMATION 295 0.0057
162 ODYNOPHAGIA 34 0.0057
163 DUODENAL ULCER 40 0.0057
164 MUSCLE FATIGUE 24 0.0057
165 GAIT INABILITY 189 0.0056
166 THERMAL BURN 40 0.0056
167 HEPATIC PAIN 24 0.0056
168 VITAMIN D DECREASED 48 0.0056
169 CHEILITIS 30 0.0055
170 PHARYNGITIS STREPTOCOCCAL 60 0.0055
171 TOOTH INFECTION 73 0.0055
172 ARTHROPATHY 307 0.0055
173 HYPERLIPIDAEMIA 66 0.0055
174 SENSITIVITY TO WEATHER CHANGE 29 0.0055
175 BLOOD PRESSURE FLUCTUATION 132 0.0055
176 OSTEOARTHRITIS 233 0.0055
177 MELANOCYTIC NAEVUS 24 0.0055
178 INJURY 384 0.0055
179 NECK PAIN 304 0.0054
180 INJECTION SITE INFLAMMATION 27 0.0054
181 SWELLING FACE 352 0.0054
182 SINUS DISORDER 107 0.0054
183 OROPHARYNGEAL PAIN 500 0.0054
184 THROAT TIGHTNESS 146 0.0054
185 PHARYNGEAL OEDEMA 83 0.0054
186 DISCOMFORT 329 0.0054
187 IMPAIRED HEALING 177 0.0054
188 SINUS HEADACHE 32 0.0054
189 GINGIVITIS 29 0.0054
190 TENDERNESS 56 0.0054
191 MUSCLE SPASTICITY 66 0.0054
192 JOINT SWELLING 648 0.0054
193 ARTHRITIS 420 0.0053
194 JOINT STIFFNESS 140 0.0053
195 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 379 0.0053
196 CHAPPED LIPS 23 0.0053
197 BLOOD PRESSURE SYSTOLIC INCREASED 103 0.0053
198 DEFAECATION URGENCY 37 0.0053
199 LIGAMENT SPRAIN 52 0.0053
200 VISUAL DISTURBANCE 30 0.0052
201 DYSPHAGIA 496 0.0052
202 GASTRITIS 137 0.0052
203 DRUG INEFFECTIVE 6860 0.0052
204 MOUTH SWELLING 30 0.0052
205 AORTIC VALVE INCOMPETENCE 22 0.0052
206 MUSCULOSKELETAL CHEST PAIN 80 0.0052
207 INTERVERTEBRAL DISC DISORDER 22 0.0051
208 PSORIATIC ARTHROPATHY 209 0.0051
209 PERONEAL NERVE PALSY 29 0.0051
210 HEPATIC LESION 22 0.0051
211 ENERGY INCREASED 30 0.0051
212 FRUSTRATION TOLERANCE DECREASED 41 0.0051
213 FAECES DISCOLOURED 110 0.0051
214 INITIAL INSOMNIA 52 0.0051
215 RENAL DISORDER 236 0.0051
216 MUSCULOSKELETAL DISCOMFORT 87 0.0050
217 FACIAL PAIN 45 0.0050
218 INTENTIONAL PRODUCT USE ISSUE 440 0.0050
219 HIATUS HERNIA 65 0.0050
220 ONYCHOMYCOSIS 22 0.0050
221 LIVER DISORDER 221 0.0050
222 RHEUMATOID ARTHRITIS 565 0.0050
223 POOR QUALITY SLEEP 107 0.0050
224 HYPERHIDROSIS 639 0.0050
225 PERICARDITIS 83 0.0049
226 GASTRITIS EROSIVE 23 0.0049
227 RENAL PAIN 52 0.0049
228 PAROSMIA 37 0.0049
229 DYSMENORRHOEA 65 0.0049
230 LIMB INJURY 133 0.0049
231 CHOKING SENSATION 27 0.0049
232 SINUS CONGESTION 66 0.0049
233 IRON DEFICIENCY ANAEMIA 45 0.0049
234 BACK INJURY 53 0.0049
235 ARTHROPOD BITE 36 0.0049
236 FREQUENT BOWEL MOVEMENTS 131 0.0048
237 FEELING DRUNK 36 0.0048
238 PRODUCT PACKAGING ISSUE 46 0.0048
239 LIVER INJURY 118 0.0048
240 NASAL DRYNESS 30 0.0048
241 CARPAL TUNNEL SYNDROME 67 0.0048
242 TENDONITIS 74 0.0048
243 FEELING JITTERY 91 0.0048
244 DRUG INTOLERANCE 460 0.0048
245 JAW DISORDER 26 0.0047
246 PRESCRIBED OVERDOSE 91 0.0047
247 TONGUE DISORDER 34 0.0047
248 ORAL PAIN 105 0.0047
249 SLEEP DISORDER 330 0.0047
250 SCAR 80 0.0047
251 ROTATOR CUFF SYNDROME 60 0.0047
252 INTERVERTEBRAL DISC PROTRUSION 102 0.0047
253 UTERINE LEIOMYOMA 34 0.0046
254 HYPOAESTHESIA 696 0.0046
255 PARAESTHESIA ORAL 67 0.0046
256 APHTHOUS ULCER 36 0.0046
257 JOINT EFFUSION 32 0.0046
258 TOOTHACHE 84 0.0046
259 SWELLING 433 0.0046
260 TINNITUS 211 0.0046
261 DRY MOUTH 371 0.0046
262 MUSCULOSKELETAL DISORDER 87 0.0046
263 HYPERSENSITIVITY 848 0.0046
264 BURNING SENSATION 320 0.0046
265 DRUG SCREEN POSITIVE 36 0.0046
266 MICTURITION URGENCY 52 0.0045
267 PIGMENTATION DISORDER 28 0.0045
268 STOMATITIS 275 0.0045
269 MOBILITY DECREASED 325 0.0045
270 INFLUENZA LIKE ILLNESS 372 0.0045
271 RECTAL HAEMORRHAGE 194 0.0045
272 MUSCLE TIGHTNESS 73 0.0045
273 SNEEZING 101 0.0045
274 RETCHING 96 0.0045
275 INFLAMMATORY BOWEL DISEASE 44 0.0045
276 STREPTOCOCCAL INFECTION 25 0.0045
277 UPPER-AIRWAY COUGH SYNDROME 37 0.0045
278 IMPAIRED DRIVING ABILITY 51 0.0045
279 HEART RATE ABNORMAL 25 0.0045
280 BLOOD PRESSURE INCREASED 685 0.0045
281 EYELID OEDEMA 52 0.0045
282 HEAD DISCOMFORT 79 0.0045
283 INCREASED TENDENCY TO BRUISE 41 0.0045
284 TRISMUS 23 0.0044
285 FEELING HOT 273 0.0044
286 BONE DISORDER 81 0.0044
287 PERIPHERAL SWELLING 684 0.0044
288 BOWEL MOVEMENT IRREGULARITY 34 0.0044
289 SPINAL PAIN 52 0.0044
290 PANIC REACTION 32 0.0044
291 NASOPHARYNGITIS 816 0.0044
292 INFUSION SITE PAIN 57 0.0044
293 ROAD TRAFFIC ACCIDENT 185 0.0044
294 URTICARIA 740 0.0044
295 NASAL DISCOMFORT 35 0.0044
296 VITAMIN D DEFICIENCY 43 0.0044
297 GINGIVAL PAIN 35 0.0044
298 GASTROOESOPHAGEAL REFLUX DISEASE 353 0.0044
299 BACK PAIN 1016 0.0044
300 GALLBLADDER DISORDER 78 0.0044
301 ORAL DISORDER 32 0.0044
302 TEMPERATURE INTOLERANCE 45 0.0044
303 FEELING ABNORMAL 1045 0.0044
304 INFUSION RELATED REACTION 289 0.0044
305 SCOLIOSIS 27 0.0044
306 LYMPHOEDEMA 30 0.0043
307 HEARING IMPAIRED 26 0.0043
308 RIB FRACTURE 89 0.0043
309 LOWER RESPIRATORY TRACT INFECTION 196 0.0043
310 OVARIAN CYST 43 0.0043
311 SKIN WARM 25 0.0043
312 FOOD POISONING 23 0.0043
313 WOUND 120 0.0043
314 PANIC ATTACK 155 0.0042
315 URINE ODOUR ABNORMAL 25 0.0042
316 BACK DISORDER 69 0.0042
317 UPPER RESPIRATORY TRACT INFECTION 196 0.0042
318 GASTROINTESTINAL DISORDER 380 0.0042
319 PHOTOSENSITIVITY REACTION 70 0.0042
320 RESTLESS LEGS SYNDROME 77 0.0042
321 MENISCUS INJURY 26 0.0042
322 HYDROCEPHALUS 23 0.0042
323 GENERALISED ERYTHEMA 24 0.0042
324 TOXIC EPIDERMAL NECROLYSIS 64 0.0042
325 BLOOD URINE PRESENT 80 0.0042
326 BLISTER 235 0.0042
327 GASTROINTESTINAL PAIN 46 0.0042
328 CARDIAC FLUTTER 27 0.0042
329 FLATULENCE 236 0.0042
330 HEADACHE 2606 0.0042
331 HOT FLUSH 313 0.0041
332 WRONG DRUG ADMINISTERED 37 0.0041
333 INSOMNIA 1105 0.0041
334 SKIN LACERATION 45 0.0041
335 CONTUSION 398 0.0041
336 HEART RATE INCREASED 409 0.0041
337 DERMATITIS CONTACT 47 0.0041
338 BLOOD DISORDER 33 0.0041
339 HIP ARTHROPLASTY 63 0.0041
340 GASTROINTESTINAL MOTILITY DISORDER 22 0.0041
341 DRUG EFFECT DECREASED 221 0.0041
342 OROPHARYNGEAL DISCOMFORT 37 0.0041
343 PAIN IN EXTREMITY 1206 0.0041
344 CHOLELITHIASIS 134 0.0041
345 RHINORRHOEA 264 0.0041
346 PARAESTHESIA 641 0.0041
347 DENTAL CARIES 45 0.0041
348 PERIORBITAL SWELLING 23 0.0041
349 PAIN 2497 0.0041
350 HAEMATEMESIS 103 0.0041
351 ARTHRALGIA 1684 0.0040
352 COLITIS ULCERATIVE 181 0.0040
353 EXTRA DOSE ADMINISTERED 164 0.0040
354 DYSURIA 149 0.0040
355 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 29 0.0040
356 ORAL HERPES 79 0.0040
357 PHOTOPHOBIA 76 0.0040
358 ATELECTASIS 39 0.0040
359 SCAB 46 0.0040
360 NEURALGIA 98 0.0040
361 TRICUSPID VALVE INCOMPETENCE 32 0.0040
362 TOOTH ABSCESS 41 0.0040
363 LOCAL SWELLING 70 0.0040
364 ANKLE FRACTURE 62 0.0040
365 MUSCLE SPASMS 735 0.0040
366 JOINT INJURY 85 0.0040
367 SENSORY LOSS 32 0.0040
368 RASH PAPULAR 89 0.0040
369 GAIT DISTURBANCE 759 0.0040
370 HEART RATE DECREASED 139 0.0040
371 CHEST PAIN 733 0.0040
372 TOOTH DISORDER 88 0.0040
373 GINGIVAL BLEEDING 54 0.0040
374 EYE PAIN 223 0.0039
375 MUSCLE DISORDER 32 0.0039
376 DYSGRAPHIA 26 0.0039
377 THERAPEUTIC RESPONSE CHANGED 25 0.0039
378 LUNG DISORDER 193 0.0039
379 DRY THROAT 40 0.0039
380 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 189 0.0039
381 BALANCE DISORDER 340 0.0039
382 CARDIAC MURMUR 34 0.0039
383 INFUSION SITE ERYTHEMA 33 0.0039
384 TOOTH FRACTURE 43 0.0039
385 EAR DISCOMFORT 40 0.0039
386 DEEP VEIN THROMBOSIS 253 0.0039
387 PROCTALGIA 25 0.0039
388 RENAL TUBULAR NECROSIS 38 0.0039
389 BLOOD PRESSURE ABNORMAL 77 0.0039
390 APHONIA 54 0.0039
391 UPPER GASTROINTESTINAL HAEMORRHAGE 65 0.0039
392 SARS-COV-2 TEST POSITIVE 51 0.0039
393 LOCALISED INFECTION 93 0.0038
394 SWOLLEN TONGUE 120 0.0038
395 DYSSTASIA 112 0.0038
396 MAJOR DEPRESSION 28 0.0038
397 FLUSHING 389 0.0038
398 INFUSION SITE SWELLING 24 0.0038
399 SOMNOLENCE 767 0.0038
400 EYE INFECTION 43 0.0038
401 TYPE 2 DIABETES MELLITUS 128 0.0038
402 MITRAL VALVE INCOMPETENCE 43 0.0038
403 FOOT FRACTURE 72 0.0038
404 PHARYNGITIS 47 0.0038
405 PRODUCT COMPLAINT 96 0.0038
406 ACTIVITIES OF DAILY LIVING IMPAIRED 75 0.0038
407 HEPATIC CIRRHOSIS 71 0.0038
408 RESPIRATORY TRACT CONGESTION 60 0.0038
409 CONJUNCTIVITIS 70 0.0038
410 RENAL FAILURE ACUTE 160 0.0038
411 HAEMATOCHEZIA 208 0.0038
412 GASTROENTERITIS VIRAL 68 0.0038
413 FOOD ALLERGY 29 0.0038
414 LYMPHADENOPATHY 133 0.0038
415 BRONCHITIS 278 0.0038
416 SUNBURN 28 0.0038
417 ANXIETY 1068 0.0037
418 DEPRESSION 852 0.0037
419 IMPAIRED WORK ABILITY 80 0.0037
420 NERVOUSNESS 195 0.0037
421 RHINITIS 30 0.0037
422 SLEEP APNOEA SYNDROME 71 0.0037
423 OSTEOPOROSIS 153 0.0037
424 PRODUCT USE ISSUE 698 0.0037
425 PRODUCTIVE COUGH 177 0.0037
426 MOUTH ULCERATION 78 0.0037
427 WRONG PRODUCT ADMINISTERED 25 0.0037
428 DISEASE RECURRENCE 176 0.0037
429 PRURITUS GENERALISED 80 0.0037
430 LABORATORY TEST ABNORMAL 109 0.0037
431 INCONTINENCE 39 0.0037
432 THERAPEUTIC PRODUCT EFFECT DECREASED 165 0.0037
433 SECRETION DISCHARGE 46 0.0037
434 FEELING COLD 102 0.0037
435 OESOPHAGITIS 40 0.0037
436 BLINDNESS TRANSIENT 27 0.0037
437 BONE PAIN 214 0.0036
438 ANHEDONIA 96 0.0036
439 BLOOD CALCIUM DECREASED 41 0.0036
440 WHEEZING 216 0.0036
441 NASAL CONGESTION 214 0.0036
442 CONSTIPATION 794 0.0036
443 VIRAL INFECTION 121 0.0036
444 RASH GENERALISED 94 0.0036
445 EYE DISORDER 119 0.0036
446 CONCUSSION 28 0.0036
447 CONDITION AGGRAVATED 1098 0.0036
448 CORONARY ARTERY DISEASE 109 0.0036
449 WHITE BLOOD CELL COUNT INCREASED 138 0.0036
450 CHROMATURIA 81 0.0036
451 LIVER FUNCTION TEST INCREASED 77 0.0036
452 MYALGIA 607 0.0036
453 HEPATIC ENZYME INCREASED 243 0.0036
454 OSTEOPENIA 54 0.0036
455 LIMB DISCOMFORT 110 0.0036
456 POLLAKIURIA 148 0.0035
457 DRY EYE 177 0.0035
458 NAIL DISORDER 31 0.0035
459 ANGINA UNSTABLE 23 0.0035
460 BLOOD CALCIUM INCREASED 31 0.0035
461 DIZZINESS 1761 0.0035
462 FLANK PAIN 33 0.0035
463 MUSCULAR WEAKNESS 400 0.0035
464 HAIR DISORDER 29 0.0035
465 HAIR TEXTURE ABNORMAL 47 0.0035
466 LACERATION 33 0.0035
467 SOMNAMBULISM 23 0.0035
468 FATIGUE 2728 0.0035
469 BLEPHAROSPASM 22 0.0035
470 THINKING ABNORMAL 65 0.0035
471 HAEMORRHOIDS 68 0.0035
472 BREAST PAIN 37 0.0035
473 NAUSEA 2746 0.0035
474 GENERAL SYMPTOM 26 0.0035
475 CYST 43 0.0035
476 HYSTERECTOMY 30 0.0035
477 VITREOUS FLOATERS 34 0.0035
478 ABDOMINAL DISTENSION 361 0.0035
479 BLOOD IRON DECREASED 41 0.0035
480 ABSCESS 55 0.0034
481 DISABILITY 68 0.0034
482 COUGH 964 0.0034
483 SLUGGISHNESS 35 0.0034
484 PAIN IN JAW 97 0.0034
485 CENTRAL NERVOUS SYSTEM LESION 47 0.0034
486 FEAR 92 0.0034
487 MOUTH HAEMORRHAGE 25 0.0034
488 INFLUENZA 378 0.0034
489 LOWER GASTROINTESTINAL HAEMORRHAGE 25 0.0034
490 SYSTEMIC LUPUS ERYTHEMATOSUS 120 0.0034
491 CHILLS 396 0.0034
492 RASH MACULAR 118 0.0034
493 HAIR COLOUR CHANGES 42 0.0034
494 MULTIPLE SCLEROSIS 161 0.0034
495 AMNESIA 219 0.0034
496 HEART RATE IRREGULAR 76 0.0034
497 CHEST DISCOMFORT 344 0.0034
498 HYPERTENSION 711 0.0034
499 HYPERSOMNIA 96 0.0033
500 ATRIAL SEPTAL DEFECT 28 0.0033
501 RESPIRATION ABNORMAL 23 0.0033
502 BLINDNESS UNILATERAL 47 0.0033
503 CYSTITIS 106 0.0033
504 MULTIPLE SCLEROSIS RELAPSE 228 0.0033
505 SKIN FISSURES 65 0.0033
506 UVEITIS 45 0.0033
507 PALPITATIONS 388 0.0033
508 ILL-DEFINED DISORDER 201 0.0033
509 TENDON PAIN 25 0.0033
510 COVID-19 579 0.0033
511 MASS 46 0.0033
512 HYPERAESTHESIA 27 0.0033
513 VERTIGO 200 0.0033
514 PERIPHERAL COLDNESS 45 0.0033
515 BLOOD TEST ABNORMAL 46 0.0033
516 BEDRIDDEN 43 0.0033
517 INSURANCE ISSUE 50 0.0033
518 CARDIOMEGALY 40 0.0032
519 PELVIC PAIN 59 0.0032
520 SENSORY DISTURBANCE 52 0.0032
521 INTERNAL HAEMORRHAGE 37 0.0032
522 LIVE BIRTH 27 0.0032
523 BLADDER DISORDER 32 0.0032
524 SKIN DISCOLOURATION 148 0.0032
525 MATERNAL EXPOSURE BEFORE PREGNANCY 22 0.0032
526 KIDNEY INFECTION 63 0.0032
527 MOVEMENT DISORDER 103 0.0032
528 TASTE DISORDER 65 0.0032
529 ABDOMINAL PAIN 744 0.0032
530 DIZZINESS POSTURAL 31 0.0032
531 EPISTAXIS 239 0.0032
532 WEIGHT INCREASED 715 0.0032
533 BRAIN FOG 50 0.0032
534 CHOLECYSTITIS 38 0.0032
535 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
536 CELLULITIS 160 0.0032
537 HYPOKINESIA 46 0.0032
538 LYMPHOCYTE COUNT DECREASED 56 0.0032
539 DECREASED ACTIVITY 34 0.0031
540 EATING DISORDER 67 0.0031
541 HEMIPARESIS 53 0.0031
542 BLOOD MAGNESIUM DECREASED 27 0.0031
543 HEPATITIS 80 0.0031
544 FUNGAL INFECTION 104 0.0031
545 SKIN DISORDER 104 0.0031
546 NEPHROPATHY 29 0.0031
547 MALAISE 1362 0.0031
548 DIARRHOEA HAEMORRHAGIC 29 0.0031
549 MADAROSIS 36 0.0031
550 PULMONARY EMBOLISM 294 0.0031
551 PRURITUS 1188 0.0031
552 BASAL CELL CARCINOMA 48 0.0031
553 HAEMATOCRIT DECREASED 61 0.0031
554 EYE HAEMORRHAGE 41 0.0031
555 CHOLECYSTECTOMY 35 0.0031
556 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 52 0.0031
557 STEVENS-JOHNSON SYNDROME 68 0.0031
558 NERVE INJURY 34 0.0031
559 SPUTUM DISCOLOURED 29 0.0031
560 LACRIMATION INCREASED 92 0.0030
561 MELAENA 67 0.0030
562 ASTHMA 344 0.0030
563 MEMORY IMPAIRMENT 418 0.0030
564 CHRONIC KIDNEY DISEASE 231 0.0030
565 KNEE ARTHROPLASTY 64 0.0030
566 MENSTRUAL DISORDER 25 0.0030
567 COORDINATION ABNORMAL 42 0.0030
568 VISION BLURRED 413 0.0030
569 CRYING 109 0.0030
570 TRANSIENT ISCHAEMIC ATTACK 101 0.0030
571 RASH PRURITIC 162 0.0030
572 TUBULOINTERSTITIAL NEPHRITIS 56 0.0030
573 OEDEMA PERIPHERAL 363 0.0030
574 SQUAMOUS CELL CARCINOMA 28 0.0030
575 VOMITING 1398 0.0030
576 LOW DENSITY LIPOPROTEIN INCREASED 23 0.0030
577 DIPLOPIA 77 0.0030
578 PHARYNGEAL SWELLING 29 0.0030
579 SPINAL DISORDER 28 0.0030
580 COLD SWEAT 52 0.0029
581 GASTROENTERITIS 43 0.0029
582 RED BLOOD CELL COUNT DECREASED 84 0.0029
583 ILLNESS 302 0.0029
584 ARTERIAL OCCLUSIVE DISEASE 23 0.0029
585 WRONG TECHNIQUE IN DRUG USAGE PROCESS 106 0.0029
586 ANAPHYLACTIC REACTION 161 0.0029
587 WEIGHT DECREASED 813 0.0029
588 SPINAL COMPRESSION FRACTURE 24 0.0029
589 GOUT 52 0.0029
590 ABNORMAL DREAMS 80 0.0029
591 ANAL INCONTINENCE 26 0.0029
592 EYE DISCHARGE 30 0.0029
593 RASH ERYTHEMATOUS 138 0.0029
594 AGEUSIA 72 0.0029
595 URINARY TRACT INFECTION 492 0.0029
596 RASH 1255 0.0029
597 ASTHENIA 1080 0.0029
598 HUNGER 40 0.0029
599 OBSESSIVE-COMPULSIVE DISORDER 23 0.0029
600 OPTIC NEURITIS 26 0.0029
601 C-REACTIVE PROTEIN INCREASED 104 0.0029
602 OCULAR DISCOMFORT 32 0.0028
603 TREMOR 473 0.0028
604 GROIN PAIN 25 0.0028
605 PRESYNCOPE 69 0.0028
606 DEPRESSED MOOD 150 0.0028
607 URINARY INCONTINENCE 84 0.0028
608 QUALITY OF LIFE DECREASED 38 0.0028
609 EUPHORIC MOOD 29 0.0028
610 LUNG INFILTRATION 25 0.0028
611 DEAFNESS 74 0.0028
612 MUSCLE TWITCHING 65 0.0028
613 IMMUNODEFICIENCY 42 0.0028
614 PULMONARY FIBROSIS 54 0.0028
615 PYREXIA 973 0.0028
616 ORAL CANDIDIASIS 37 0.0028
617 RESPIRATORY DISORDER 84 0.0028
618 THERAPEUTIC RESPONSE SHORTENED 93 0.0028
619 HERPES ZOSTER 161 0.0028
620 DIARRHOEA 1808 0.0028
621 MENORRHAGIA 55 0.0028
622 THIRST 50 0.0028
623 HERNIA 54 0.0028
624 ABASIA 69 0.0028
625 MOOD SWINGS 89 0.0028
626 ANGINA PECTORIS 80 0.0028
627 HEPATIC STEATOSIS 52 0.0028
628 DYSPNOEA EXERTIONAL 105 0.0028
629 CATARACT 166 0.0028
630 BLOOD ALBUMIN DECREASED 22 0.0028
631 ABDOMINAL PAIN LOWER 70 0.0028
632 VAGINAL DISCHARGE 28 0.0028
633 DELIRIUM 96 0.0028
634 OEDEMA 150 0.0028
635 RESPIRATORY TRACT INFECTION 72 0.0028
636 OSTEOMYELITIS 50 0.0028
637 FEEDING DISORDER 56 0.0028
638 URINARY RETENTION 92 0.0028
639 DYSPHONIA 161 0.0028
640 GASTROINTESTINAL HAEMORRHAGE 230 0.0027
641 WHITE BLOOD CELL COUNT DECREASED 298 0.0027
642 METASTASES TO BONE 45 0.0027
643 ALOPECIA 538 0.0027
644 ANAPHYLACTIC SHOCK 70 0.0027
645 IMPAIRED GASTRIC EMPTYING 37 0.0027
646 DISTURBANCE IN ATTENTION 146 0.0027
647 RESPIRATORY RATE INCREASED 24 0.0027
648 INJECTION SITE INDURATION 35 0.0027
649 CORONARY ARTERY OCCLUSION 37 0.0027
650 METRORRHAGIA 46 0.0027
651 VENTRICULAR EXTRASYSTOLES 28 0.0027
652 ANOSMIA 39 0.0027
653 HEAD INJURY 85 0.0027
654 MUSCLE ATROPHY 34 0.0027
655 WRIST FRACTURE 32 0.0027
656 DECREASED APPETITE 620 0.0027
657 SPEECH DISORDER 139 0.0027
658 TOOTH EXTRACTION 33 0.0026
659 NEUROPATHY PERIPHERAL 252 0.0026
660 THERAPY CHANGE 26 0.0026
661 INFECTION 382 0.0026
662 ANOREXIA 34 0.0026
663 GENERAL PHYSICAL HEALTH DETERIORATION 303 0.0026
664 FALL 870 0.0026
665 OCULAR HYPERAEMIA 124 0.0026
666 FACE OEDEMA 44 0.0026
667 PLATELET COUNT INCREASED 34 0.0026
668 DIVERTICULITIS 72 0.0026
669 BODY TEMPERATURE INCREASED 53 0.0026
670 LEUKOCYTOSIS 47 0.0026
671 ERYTHEMA 533 0.0026
672 ERUCTATION 50 0.0026
673 IMMUNE SYSTEM DISORDER 34 0.0026
674 PULMONARY CONGESTION 34 0.0026
675 END STAGE RENAL DISEASE 47 0.0026
676 PRODUCT CONTAINER ISSUE 22 0.0026
677 GASTROINTESTINAL INFECTION 23 0.0026
678 EYELID PTOSIS 26 0.0026
679 RENAL INJURY 76 0.0026
680 DYSPNOEA 1448 0.0026
681 KNEE OPERATION 25 0.0025
682 EYE PRURITUS 85 0.0025
683 UNEVALUABLE EVENT 191 0.0025
684 EYE INFLAMMATION 24 0.0025
685 THERAPY NON-RESPONDER 113 0.0025
686 ACCIDENT 30 0.0025
687 OXYGEN SATURATION DECREASED 141 0.0025
688 MALNUTRITION 28 0.0025
689 SKIN HAEMORRHAGE 37 0.0025
690 PROCEDURAL PAIN 69 0.0025
691 TOXIC SKIN ERUPTION 25 0.0025
692 SPLENOMEGALY 29 0.0025
693 PRODUCT SUBSTITUTION ISSUE 142 0.0025
694 HAEMOGLOBIN DECREASED 253 0.0025
695 INCREASED APPETITE 47 0.0025
696 IRRITABILITY 147 0.0024
697 BLOOD SODIUM DECREASED 46 0.0024
698 HAEMOPTYSIS 68 0.0024
699 CONFUSIONAL STATE 393 0.0024
700 TENDON RUPTURE 30 0.0024
701 DEHYDRATION 324 0.0024
702 BLOOD POTASSIUM DECREASED 73 0.0024
703 ANGER 82 0.0024
704 OVERDOSE 523 0.0024
705 MOOD ALTERED 66 0.0024
706 APHASIA 73 0.0024
707 PULMONARY MASS 36 0.0024
708 POOR VENOUS ACCESS 25 0.0024
709 HYPOTHYROIDISM 77 0.0024
710 RENAL FAILURE 320 0.0024
711 INJECTION SITE URTICARIA 59 0.0024
712 SUICIDAL IDEATION 220 0.0024
713 FISTULA 27 0.0024
714 THYROID DISORDER 37 0.0024
715 PREGNANCY 48 0.0024
716 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 431 0.0024
717 INJECTION SITE RASH 73 0.0024
718 ACCIDENTAL OVERDOSE 87 0.0024
719 INJECTION SITE DISCOMFORT 25 0.0024
720 ACUTE MYOCARDIAL INFARCTION 70 0.0024
721 PRODUCT QUALITY ISSUE 322 0.0024
722 ALANINE AMINOTRANSFERASE INCREASED 145 0.0024
723 UPPER LIMB FRACTURE 47 0.0024
724 SMALL INTESTINAL OBSTRUCTION 29 0.0024
725 PRESCRIBED UNDERDOSE 47 0.0024
726 APPENDICITIS 22 0.0024
727 SPINAL OPERATION 29 0.0024
728 DRUG TOXICITY 32 0.0023
729 NEUTROPHIL COUNT INCREASED 24 0.0023
730 INCORRECT DOSE ADMINISTERED 534 0.0023
731 ARTERIOSCLEROSIS 22 0.0023
732 BLOOD ALKALINE PHOSPHATASE INCREASED 58 0.0023
733 PRODUCT DOSE OMISSION IN ERROR 66 0.0023
734 EMOTIONAL DISTRESS 282 0.0023
735 INTENTIONAL OVERDOSE 149 0.0023
736 VISUAL IMPAIRMENT 287 0.0023
737 LETHARGY 133 0.0023
738 BLOOD COUNT ABNORMAL 35 0.0023
739 NOCTURIA 28 0.0023
740 STAPHYLOCOCCAL INFECTION 76 0.0023
741 EMOTIONAL DISORDER 71 0.0023
742 THERAPY CESSATION 118 0.0023
743 THROMBOSIS 184 0.0023
744 SCRATCH 24 0.0023
745 BLOOD TRIGLYCERIDES INCREASED 40 0.0023
746 APATHY 33 0.0023
747 MACULAR DEGENERATION 27 0.0023
748 SKIN LESION 62 0.0023
749 DYSARTHRIA 85 0.0023
750 SKIN EXFOLIATION 190 0.0022
751 PSORIASIS 294 0.0022
752 COGNITIVE DISORDER 105 0.0022
753 INTENTIONAL DOSE OMISSION 64 0.0022
754 HEPATOMEGALY 22 0.0022
755 WITHDRAWAL SYNDROME 94 0.0022
756 GLAUCOMA 43 0.0022
757 SKIN INFECTION 25 0.0022
758 NODULE 29 0.0022
759 MATERNAL EXPOSURE DURING PREGNANCY 197 0.0022
760 DRY SKIN 295 0.0022
761 PARANOIA 38 0.0022
762 PANCREATITIS 116 0.0022
763 ATAXIA 26 0.0022
764 EYE IRRITATION 126 0.0022
765 HYPOKALAEMIA 101 0.0022
766 FLUID RETENTION 111 0.0022
767 HAEMORRHAGE 228 0.0022
768 EMPHYSEMA 22 0.0022
769 PRODUCT ADMINISTRATION ERROR 44 0.0022
770 FULL BLOOD COUNT ABNORMAL 23 0.0022
771 BRONCHOSPASM 31 0.0022
772 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
773 PARALYSIS 31 0.0022
774 IMPAIRED QUALITY OF LIFE 31 0.0022
775 BLOOD PRESSURE DECREASED 143 0.0022
776 HIP FRACTURE 69 0.0021
777 MENTAL IMPAIRMENT 52 0.0021
778 BACTERIAL INFECTION 40 0.0021
779 HYPOACUSIS 92 0.0021
780 CANDIDA INFECTION 36 0.0021
781 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 39 0.0021
782 SINUS TACHYCARDIA 30 0.0021
783 HYPOPHAGIA 54 0.0021
784 ECONOMIC PROBLEM 32 0.0021
785 PLATELET COUNT DECREASED 225 0.0021
786 INJECTION SITE BRUISING 168 0.0021
787 TREATMENT FAILURE 172 0.0021
788 ACNE 157 0.0021
789 HEREDITARY ANGIOEDEMA 22 0.0020
790 INJECTION SITE REACTION 141 0.0020
791 PANCREATITIS ACUTE 46 0.0020
792 INJECTION SITE WARMTH 42 0.0020
793 BLINDNESS 83 0.0020
794 ADVERSE REACTION 27 0.0020
795 MEDICATION ERROR 113 0.0020
796 SYNCOPE 203 0.0020
797 LIVER FUNCTION TEST ABNORMAL 59 0.0020
798 MYDRIASIS 26 0.0020
799 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 144 0.0020
800 ANAEMIA 386 0.0020
801 PLEURAL EFFUSION 123 0.0020
802 GENERALISED OEDEMA 25 0.0020
803 LOSS OF CONSCIOUSNESS 258 0.0020
804 SKIN ULCER 52 0.0020
805 CONVULSION 115 0.0020
806 INJECTION SITE ERYTHEMA 249 0.0020
807 DERMATITIS 42 0.0020
808 BLOOD BILIRUBIN INCREASED 54 0.0020
809 PNEUMONITIS 54 0.0020
810 DISORIENTATION 78 0.0020
811 INCORRECT DRUG ADMINISTRATION DURATION 55 0.0020
812 ECZEMA 102 0.0019
813 PALLOR 53 0.0019
814 SPINAL FRACTURE 39 0.0019
815 ASPARTATE AMINOTRANSFERASE INCREASED 103 0.0019
816 NEOPLASM PROGRESSION 67 0.0019
817 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 33 0.0019
818 SUICIDE ATTEMPT 116 0.0019
819 BLOOD UREA INCREASED 32 0.0019
820 CARDIAC DISORDER 178 0.0019
821 OSTEONECROSIS OF JAW 47 0.0019
822 PAIN OF SKIN 51 0.0019
823 INJECTION SITE MASS 70 0.0019
824 POST PROCEDURAL HAEMORRHAGE 22 0.0019
825 FULL BLOOD COUNT DECREASED 38 0.0019
826 CEREBROVASCULAR ACCIDENT 319 0.0019
827 INJECTION SITE PRURITUS 126 0.0019
828 ACUTE RESPIRATORY FAILURE 36 0.0019
829 LUNG INFECTION 29 0.0019
830 HALLUCINATION 140 0.0019
831 SURGERY 108 0.0018
832 PNEUMONIA 596 0.0018
833 INJECTION SITE DISCOLOURATION 23 0.0018
834 MENTAL DISORDER 80 0.0018
835 AGITATION 135 0.0018
836 RESTLESSNESS 67 0.0018
837 ERECTILE DYSFUNCTION 47 0.0018
838 ADVERSE DRUG REACTION 164 0.0018
839 MYOCARDIAL INFARCTION 318 0.0018
840 POST PROCEDURAL COMPLICATION 35 0.0018
841 HYPOTENSION 365 0.0018
842 INTENTIONAL DRUG MISUSE 38 0.0018
843 SKIN BURNING SENSATION 130 0.0018
844 DELUSION 28 0.0018
845 INJECTION SITE SWELLING 138 0.0018
846 THERAPEUTIC RESPONSE DECREASED 109 0.0018
847 BONE LOSS 27 0.0018
848 COLITIS 68 0.0018
849 DRUG ADMINISTRATION ERROR 55 0.0018
850 SKIN IRRITATION 82 0.0018
851 HYPERGLYCAEMIA 65 0.0018
852 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 93 0.0018
853 TACHYCARDIA 158 0.0018
854 INTESTINAL OBSTRUCTION 67 0.0018
855 DYSKINESIA 72 0.0018
856 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
857 PNEUMOTHORAX 28 0.0018
858 MENTAL STATUS CHANGES 49 0.0018
859 HEPATIC FAILURE 53 0.0018
860 VAGINAL HAEMORRHAGE 76 0.0017
861 DERMATITIS ALLERGIC 22 0.0017
862 PRODUCT DOSE OMISSION ISSUE 512 0.0017
863 RESPIRATORY DISTRESS 48 0.0017
864 OFF LABEL USE 1522 0.0017
865 HYPOXIA 61 0.0017
866 ACUTE KIDNEY INJURY 265 0.0017
867 DIABETES MELLITUS 132 0.0017
868 HAEMATURIA 59 0.0017
869 GAMMA-GLUTAMYLTRANSFERASE INCREASED 38 0.0017
870 PRODUCT DOSE OMISSION 111 0.0017
871 DRUG-INDUCED LIVER INJURY 53 0.0017
872 COLON CANCER 25 0.0017
873 ANGIOEDEMA 73 0.0016
874 SKIN CANCER 35 0.0016
875 PRODUCT AVAILABILITY ISSUE 37 0.0016
876 RASH MACULO-PAPULAR 36 0.0016
877 INJECTION SITE PAIN 495 0.0016
878 MENSTRUATION IRREGULAR 43 0.0016
879 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
880 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 54 0.0016
881 JAUNDICE 43 0.0016
882 INJECTION SITE HAEMORRHAGE 127 0.0016
883 ABNORMAL BEHAVIOUR 63 0.0016
884 MANIA 26 0.0016
885 HALLUCINATION, VISUAL 33 0.0016
886 BLOOD CREATININE INCREASED 101 0.0015
887 ASCITES 45 0.0015
888 ATRIAL FIBRILLATION 149 0.0015
889 HYPONATRAEMIA 86 0.0015
890 DRUG DOSE OMISSION 252 0.0015
891 ISCHAEMIC STROKE 27 0.0015
892 COAGULOPATHY 25 0.0015
893 APPLICATION SITE PAIN 33 0.0015
894 THERAPY INTERRUPTED 107 0.0015
895 TOOTH LOSS 31 0.0015
896 SEIZURE 172 0.0015
897 CARDIOMYOPATHY 22 0.0015
898 NERVOUS SYSTEM DISORDER 46 0.0015
899 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 34 0.0015
900 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 293 0.0014
901 BLOOD POTASSIUM INCREASED 23 0.0014
902 VISUAL ACUITY REDUCED 47 0.0014
903 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
904 DISEASE PROGRESSION 167 0.0014
905 UNDERDOSE 103 0.0014
906 METABOLIC ACIDOSIS 45 0.0014
907 CYANOSIS 22 0.0014
908 CEREBRAL INFARCTION 34 0.0014
909 DRUG LEVEL INCREASED 23 0.0014
910 PHARMACEUTICAL PRODUCT COMPLAINT 36 0.0014
911 INCORRECT PRODUCT ADMINISTRATION DURATION 30 0.0014
912 PULMONARY OEDEMA 62 0.0014
913 DRUG INTERACTION 219 0.0014
914 CARDIOVASCULAR DISORDER 35 0.0014
915 ADVERSE EVENT 126 0.0014
916 DEMENTIA 38 0.0014
917 CHOLESTASIS 26 0.0014
918 HAEMATOMA 35 0.0013
919 THROMBOCYTOPENIA 147 0.0013
920 BONE DENSITY DECREASED 41 0.0013
921 EXPOSURE DURING PREGNANCY 81 0.0013
922 TREATMENT NONCOMPLIANCE 71 0.0013
923 PNEUMONIA ASPIRATION 32 0.0013
924 BLOOD GLUCOSE INCREASED 241 0.0013
925 NEUTROPHIL COUNT DECREASED 52 0.0013
926 RENAL IMPAIRMENT 106 0.0013
927 CEREBRAL HAEMORRHAGE 45 0.0013
928 AMENORRHOEA 22 0.0013
929 PERICARDIAL EFFUSION 29 0.0013
930 METASTASES TO LIVER 22 0.0013
931 LEUKOPENIA 62 0.0012
932 NEUTROPENIA 165 0.0012
933 DERMATITIS ATOPIC 62 0.0012
934 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
935 AGGRESSION 57 0.0011
936 CARDIAC FAILURE CONGESTIVE 91 0.0011
937 SEPSIS 126 0.0011
938 SEPTIC SHOCK 49 0.0011
939 TRANSAMINASES INCREASED 25 0.0011
940 HEPATOTOXICITY 25 0.0011
941 EPILEPSY 34 0.0011
942 PLASMA CELL MYELOMA 43 0.0011
943 APPLICATION SITE PRURITUS 25 0.0011
944 PRODUCT PRESCRIBING ERROR 26 0.0011
945 FEBRILE NEUTROPENIA 71 0.0011
946 RESPIRATORY FAILURE 78 0.0011
947 ENCEPHALOPATHY 26 0.0011
948 DEVICE DISLOCATION 46 0.0011
949 ARRHYTHMIA 50 0.0011
950 PSYCHOTIC DISORDER 31 0.0010
951 UNRESPONSIVE TO STIMULI 27 0.0010
952 MUCOSAL INFLAMMATION 27 0.0010
953 COMA 48 0.0010
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
955 BRADYCARDIA 53 0.0010
956 ACCIDENTAL EXPOSURE TO PRODUCT 101 0.0010
957 DRUG WITHDRAWAL SYNDROME 84 0.0010
958 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
959 OSTEONECROSIS 30 0.0009
960 MALIGNANT NEOPLASM PROGRESSION 93 0.0009
961 NEOPLASM MALIGNANT 60 0.0009
962 ABORTION SPONTANEOUS 36 0.0009
963 BLOOD GLUCOSE DECREASED 43 0.0009
964 EXPOSURE VIA SKIN CONTACT 22 0.0008
965 APPLICATION SITE ERYTHEMA 22 0.0008
966 PREMATURE BABY 25 0.0008
967 PANCYTOPENIA 45 0.0008
968 LUNG NEOPLASM MALIGNANT 33 0.0008
969 DEVICE ISSUE 72 0.0008
970 HYPERKALAEMIA 28 0.0008
971 DRUG EXPOSURE DURING PREGNANCY 27 0.0008
972 DRUG DEPENDENCE 126 0.0008
973 RHABDOMYOLYSIS 32 0.0008
974 CARDIO-RESPIRATORY ARREST 32 0.0008
975 PRODUCT ADHESION ISSUE 27 0.0008
976 FOETAL EXPOSURE DURING PREGNANCY 57 0.0007
977 HOSPITALISATION 103 0.0007
978 BREAST CANCER 62 0.0007
979 PRODUCT STORAGE ERROR 57 0.0007
980 DEVICE BREAKAGE 26 0.0006
981 HYPOGLYCAEMIA 31 0.0006
982 HEPATIC FUNCTION ABNORMAL 23 0.0006
983 DEVICE MALFUNCTION 43 0.0006
984 CARDIAC ARREST 49 0.0006
985 DRUG ABUSE 48 0.0006
986 NO ADVERSE EVENT 95 0.0005
987 DEATH 437 0.0005
988 TOXICITY TO VARIOUS AGENTS 84 0.0005
989 DEVICE DIFFICULT TO USE 28 0.0004
990 DEPENDENCE 22 0.0004
991 CARDIAC FAILURE 32 0.0004
992 PROSTATE CANCER 32 0.0004
993 COMPLETED SUICIDE 31 0.0004